>

Sichuan Xieli Pharmace audit report | Rephine

The following Rephine audit reports are available for Sichuan Xieli Pharmaceutical Co., Ltd:

Sichuan Xieli Pharmaceutical Co., Ltd


To get more information on audit reports by Rephine, please click the green button below to get contacted by Rephine!

 

What is a Sichuan Xieli Pharmaceutical Co., Ltd audit report?

Here you can find the GMP Audit Report for Sichuan Xieli Pharmaceutical Co., Ltd.

This audit report is accessible to other pharmaceutical companies, providing a detailed evaluation of Sichuan Xieli Pharmaceutical Co., Ltd's compliance with industry standards and regulations. What makes this report stand out? It's a deep dive into the company's operations, spotlighting their stringent adherence to industry norms, evidenced by certifications like GMP, CEP, DMF.

An audit report in the pharmaceutical realm is more than a mere document; it's a mirror reflecting a company's commitment to regulatory compliance, quality control, and internal policies. This report isn't just a checklist – it's a narrative showcasing how Sichuan Xieli Pharmaceutical Co., Ltd aligns with the highest standards of Good Manufacturing Practices (GMP) and beyond. It doesn't just highlight compliance; it uncovers potential areas for enhancement, offering pathways for continuous improvement.


When do you need an audit report?

Utilizing this report means it's no longer necessary to audit this supplier yourself. The availability of this report demonstrates Sichuan Xieli Pharmaceutical Co., Ltd's commitment to transparency and adherence to quality standards. It serves as a valuable tool for businesses looking to partner with or procure services from Sichuan Xieli Pharmaceutical Co., Ltd, ensuring a well-informed and secure decision-making process. For further details and to access the full Sichuan Xieli Pharmaceutical Co., Ltd GMP Audit Report contact us.

Pharmaoffer is dedicated to enhancing transparency and trust within the pharmaceutical industry, and this report is a key component of that mission. Would you like to learn more about it, click here and someone from the Rephine team will reach out to you.

How much does an audit report cost?

The cost of a Good Manufacturing Practice (GMP) audit report can vary significantly based on several factors. Here's a general overview: 

  • Complexity of the Facility: The more complex the manufacturing processes and facilities, the more in-depth the audit will be, leading to higher costs.

  • Industry and Product Type: Certain industries, like pharmaceuticals, biotechnology, and food, have stringent GMP requirements, which can make audits more expensive due to the specialized knowledge and thoroughness required.

  • Location of the Facility: Geographical location can impact costs due to travel expenses for the auditors, local economic conditions, and regulatory variations.

  • Audit Duration: The length of time needed to complete the audit also plays a role. A larger facility or one with more complex processes may require more time to audit thoroughly.

  • Scope of the Audit: The specific requirements of the GMP audit (like whether it's for the entire organization or specific processes) can affect the price.

For a precise and detailed quotation that is specifically tailored to the Sichuan Xieli Pharmaceutical Co., Ltd’s facility and operational scope, we encourage you to contact Rephine directly.

Rephine APIs on Pharmaoffer

Global experts in quality assurance & GxP compliance.

Providing specialists quality assurance services for more than 25 years.

Highly qualified experts operating across the globe

Our services:

GMP Audit Services
Third party audits
GxP Consultancy
Quality Assurance
Regulatory Compliance

Response time:

Sichuan Xieli Pharmace

Sichuan Xieli Pharmaceutical Co., Ltd. was founded in 1980 with the development concept of "Xieli Tongchuang Health Cause". It mainly engages in the cultivation of ecological medicinal materials, the extraction of natural active ingredients from animals and plants, and the synthesis and research of their derivatives. It is based on the production of high value-added export products. There are mainly dozens of varieties, including rutin based cardiovascular and cerebrovascular drugs, plant flavonoids based capillary drugs, plant derived anti-tumor drugs, animal and plant extracts, and pharmaceutical intermediates. Among them, 27 varieties have obtained national drug registration approvals. Guided by internationally advanced drug production quality management practices and standards, the company has passed certifications such as the US FDA, EU GMP, and Japan GMP, and has completed drug registration in dozens of countries including Europe, America, Japan, Eastern Europe, and Southeast Asia. Our products are mainly exported to nearly 50 countries and regions such as the European Union, Eastern Europe, South America, and Southeast Asia, entering the mainstream market of international raw material drugs and the core supply chain system of the world's 500 mandatory drug giants. Our export volume of multiple products ranks first in the same variety of domestic exports, making us a globally renowned raw material drug supplier. The company adheres to the industrialization concept of "specialization, refinement, and innovation", follows an international path, guided by the highest international standards and quality management system, and improves the domestic and foreign market competitiveness of plant raw materials and drugs through self-developed natural active ingredient extraction technology for animals and plants, and quality indicators from developed countries such as Europe, America, and Japan as standards. Over the years, the company has actively participated in the counterpart assistance of Pengzhou City to Heishui County in Targeted Poverty Alleviation and rural revitalization, which has led to continuous income increase of farmers. Commended by the provincial party committee and government for their "Advanced Collective in Counterpart Assistance to Poverty stricken Counties in Yi District of Tibet", they have been awarded the title of "Advanced Collective in Counterpart Assistance to Tibetan Areas in Chengdu" and "Model of Counterpart Assistance and Cooperation" in Aba Prefecture. The company is a national high-tech enterprise, one of the top ten export enterprises in China's plant extraction industry, one of the top 100 international pharmaceutical enterprises in China, a provincial foreign trade development demonstration base enterprise, the first and second prizes of Sichuan Science and Technology Progress Award, a famous brand in Sichuan, a provincial key leading enterprise in agricultural industrialization, a small and medium-sized enterprise in Sichuan Province with "expertise, excellence and novelty", and one of the top 20 manufacturing enterprises in Pengzhou City. We have three production bases with a total of 3245 square meters of 100000 level purification workshops, and have successfully applied for DMF registration and CEP in Europe, America, and Japan. We have also passed official GMP certifications at home and abroad, such as EDQM, FDA, PMDA, NMPA, COFEPRIS, and MHRA, multiple times. The company adheres to long-term investment in EHS and has passed the PSCI on-site audit. We have 23 products with domestic approval numbers and have long-term cooperation with major pharmaceutical factories in China.